What Radiometer does

Radiometer Medical ApS is a Denmark-based medical technology company specializing in point-of-care (POC) acute care diagnostics, with headquarters in Brønshøj and operations spanning 109+ countries supported by a workforce of 4,375+ across 68 nationalities. Founded in 1935 and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), Radiometer launched the world's first commercially available blood gas analyzer in 1954 and has maintained category leadership in acute care testing for more than 70 years.

The product portfolio spans three interconnected pillars: (1) blood gas analyzers (ABL90 FLEX, ABL90 FLEX PLUS, and related ABL-series instruments) that deliver up to 19 parameters including blood gases, electrolytes, metabolites, and oximetry from a 65 µL sample in 35 seconds; (2) the AQT90 FLEX immunoassay analyzer for cardiac, infection, and pregnancy biomarkers; and (3) the TCM5 transcutaneous monitor for continuous non-invasive oxygen and CO2 tracking. These instruments are supported by proprietary consumables (safePICO syringes, safeCLINITUBES capillary tubes, QUALICHECK+ QC ampoules), a POC IT software layer (AQURE for centralized device and operator management, Quality Manager for cloud-based compliance, and the 1st Automatic workflow automation solution), and the wholly-owned HemoCue subsidiary covering hemoglobin and diabetes POC testing. The company holds an extensive US patent portfolio across analyzer systems, transcutaneous monitoring, sampling devices, and the AQURE platform.

Radiometer operates an enterprise field sales model selling directly to hospitals, emergency departments, ICUs, NICUs, sleep clinics, and clinical laboratories through regional offices and a global distribution network. Revenue is generated through capital equipment sales (analyzers, monitors), recurring consumables sales (syringes, tubes, QC ampoules, reagent cassettes), and subscription-based software and services (AQURE, Quality Manager). The end market is healthcare providers processing approximately 1 million samples per day and impacting roughly 24 million patients annually across more than 109 countries.

Name

Radiometer

Legal name

Radiometer Medical ApS

Website

https://radiometer.dk

Company type

Private

Founded year

1935

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Radiometer is a Danish point-of-care diagnostics company and wholly-owned Danaher subsidiary that manufactures blood gas analyzers, immunoassay systems, transcutaneous monitors, and connected POC IT software for hospitals, emergency departments, ICUs, and NICUs across 109+ countries.

Ownership category

akta.pro rank

Product category

Acute Care Point-of-Care Diagnostics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI), Diagnostic & Triage Decision Support (HLACAGAA)

Keywords

• Blood gas analyzers
• Point-of-care diagnostics
• Acute care testing
• Immunoassay analyzers
• Transcutaneous monitoring

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Blood Gas Analyzers and Instruments: Sale of medical diagnostic instruments including ABL90 FLEX, ABL90 FLEX PLUS, ABL800 FLEX blood gas analyzers, and TCM transcutaneous monitors. Revenue from capital equipment sales to hospitals and healthcare facilities.
2. Consumables and Sampling Devices: Recurring revenue from consumables including safePICO syringes, safeCLINITUBES capillary tubes, QUALICHECK+ QC ampoules, and reagent cassettes. These are recurring purchases required for operation of diagnostic instruments.
3. POC IT Solutions and Software: AQURE point-of-care IT management system, Quality Manager cloud-based solution, and software services for device connectivity, data management, and quality compliance.
4. Immunoassay Testing: AQT90 FLEX immunoassay system testing for nine different biomarkers including infection, heart failure, pregnancy, venous thromboembolism, and myocardial infarction with results in 11-21 minutes.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Radiometer designs, manufactures, and sells acute care point-of-care diagnostic systems, primarily blood gas analyzers (ABL90 FLEX PLUS, ABL90 FLEX, ABL-series), an immunoassay analyzer (AQT90 FLEX), and transcutaneous monitors (TCM5/TCM CombiM), supported by sampling devices (safePICO syringes, safeCLINITUBES), quality control consumables (QUALICHECK+), and POC IT software (AQURE, Quality Manager, 1st Automatic). Products are sold to hospitals, emergency departments, ICUs, NICUs, sleep clinics, and clinical laboratories in 109+ countries.

Product overview

Radiometer is a medical technology company specializing in acute care point-of-care testing (POCT) diagnostics. The portfolio consists of three interconnected pillars: (1) a suite of blood gas analyzers (ABL90 FLEX PLUS, ABL90 FLEX, and related ABL-series instruments) delivering rapid results for blood gases, electrolytes, metabolites, and oximetry; (2) an immunoassay analyzer (AQT90 FLEX) for cardiac, infection, and pregnancy biomarkers; and (3) transcutaneous monitoring (TCM5/TCM CombiM) for continuous non-invasive oxygen and CO2 tracking. These analyzers are supported by a comprehensive ecosystem of sampling devices (safePICO syringes, safeCLINITUBES capillary tubes), quality control consumables (QUALICHECK+), and POC IT/software solutions — notably AQURE for centralized device and operator management, Quality Manager for cloud-based quality oversight, and the 1st Automatic workflow automation solution. The entire portfolio is tied together under the Radiometer brand, with HemoCue (acquired brand) covering hematology and diabetes testing. The company has operated since 1954 and is a subsidiary of Danaher Corporation.

Differentiator

Problem solved

Functional benefit

Brands

• ABL: Blood gas analyzer product line including ABL90 FLEX, ABL90 FLEX PLUS, ABL800 FLEX, ABL9, and related models
• AQT
• AQURE
• TCM
• PICO
• QUALICHECK
• safePICO
• safeCLINITUBES
• VET90
• RADchat
• HemoCue
• 1st Automatic
• NeoOne

Products and services

• ABL90 FLEX PLUS Blood Gas Analyzer A compact point-of-care blood gas analyzer for emergency, intensive, and neonatal care settings. Delivers results for up to 19 parameters (blood gases, electrolytes, metabolites, oximetry) in 35 seconds from a 65 µL blood sample, with Automatic Quality Management (AQM), automatic sample mixing, >23 hours uptime between interventions, and built-in cybersecurity.
• ABL90 FLEX Blood Gas Analyzer

Quantifiable outcome

• 10 samples analyzed every second with Radiometer devices worldwide
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Three partnerships are on record, tiered historical and core.

• CarlsberghistoricalStrategic or Co-development Partner · 1 January 1954Carlsberg was Radiometer's first partnership, dating back to the company's origins. This historical partnership marked the beginning of Radiometer's collaborative approach to innovation in medical diagnostics.
• Danaher CorporationcoreOthersRadiometer is a subsidiary of Danaher Corporation, a global science and technology company. As part of Danaher, Radiometer benefits from the Danaher Business System and collaborates with 50+ operating companies within the group. Danaher reported approximately $23.9 billion in 2024 revenue.
• HemoCuecoreStrategic or Co-development PartnerHemoCue is part of the Radiometer group, providing hemoglobin and diabetes point-of-care testing products. HemoCue products are available through Hemocue.dk, expanding Radiometer's hematology and diabetes product portfolio.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Werfen: Werfen (owner of Instrumentation Laboratory and GEM Premier) is the closest direct competitor in hospital POC blood gas analysis, with the GEM Premier series targeting the same ED/ICU customer workflows as Radiometer's ABL analyzers.
• Siemens Healthineers: Siemens Healthineers sells the RAPIDPoint and epoc blood gas/CREAT analyzers for POC and central-lab use, competing head-to-head with Radiometer in hospital acute care settings.
• Abbott: Abbott's i-STAT system is a widely deployed handheld blood gas and immunoassay POC analyzer, directly overlapping with Radiometer's ABL and AQT product lines across ED, ICU, and OR use cases.
• Roche Diagnostics: Roche's cobas b 123 POC blood gas analyzer and broader cobas hospital diagnostics portfolio compete with Radiometer for hospital lab and POC blood gas share, particularly in European markets.
• Nova Biomedical: Nova Biomedical manufactures the Stat Profile series of critical care blood gas analyzers, directly comparable to Radiometer's ABL analyzers in hospital and clinical laboratory use cases.
• OPTI Medical / IDEXX: OPTI Medical (a division of IDEXX) produces the OPTI CCA-TS2 blood gas analyzer, a smaller-volume competitor to Radiometer in hospital POC blood gas testing.
• Instrumentation Laboratory (a Werfen company): IL (Werfen) sells the GEM Premier 5000 and related blood gas/co-oximetry systems, directly competing with Radiometer in critical care and perioperative diagnostics.

Broad incumbents

• Beckman Coulter Diagnostics: Beckman Coulter Diagnostics is a Danaher sibling company in clinical chemistry and immunoassay diagnostics; it overlaps thematically with Radiometer as part of the broader Danaher Diagnostics portfolio but does not specialize in POC blood gas.

Others

• Cepheid: Cepheid, also a Danaher Diagnostics subsidiary, focuses on molecular diagnostics (GeneXpert). It is a corporate sibling rather than a direct competitor but represents adjacent Danaher Diagnostics capacity and a channel into hospital labs that could partner with Radiometer.

Emerging players

• Masimo: Masimo's pulse CO-oximetry and non-invasive patient monitoring technologies (e.g., rainbow SET) compete with and complement Radiometer's transcutaneous TCM monitors and blood gas franchise, particularly in neonatal and critical care monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/radiometermedical
• Facebookfacebook.com/radiometermedical
• LinkedInlinkedin.com/company/radiometer-medical
• Xx.com/radiometermed

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Radiometer